Cldn5 expression was significantly elevated in malignant cSCC lesions compared to non-malignant flat warts, suggesting Cldn5 may serve as a prognostic biomarker for EpV-associated skin cancer progression. This evidence concerns the gene CLDN5 and skin squamous cell carcinoma.